FDA Inspection
Algunas Inc., dba Woodland Hills Compounding PharmacyAlgunas Inc., dba Woodland Hills Compounding Pharmacy – FDA Inspection, Oct 11, 2018
Record Details
This FDA Inspection record concerns Algunas Inc., dba Woodland Hills Compounding Pharmacy, with an inspection on October 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 11, 2018
- Product Type
- Drugs
View Company Profile
ID · 885daeff-c46c-483c-bd16-a66db3b07c45
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1069078
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Algunas Inc., dba Woodland Hills Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 29, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Algunas Inc., dba Woodland Hills Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.